Portal de Periódicos da CAPES

Prevalence and Characteristics of Familial Hyperaldosteronism

2011; Lippincott Williams & Wilkins; Volume: 58; Issue: 5 Linguagem: Inglês

10.1161/hypertensionaha.111.175083

1524-4563

Paolo Mulatero, Davide Tizzani, Andrea Viola, Chiara Bertello, Silvia Monticone, Giulio Mengozzi, Domenica Schiavone, Tracy Ann Williams, Silvia Einaudi, Antonio La Grotta, Franco Rabbia, Franco Veglio,

Cardiovascular, Neuropeptides, and Oxidative Stress Research

Primary aldosteronism (PA) is the most frequent cause of secondary hypertension, and patients display an increased prevalence of cardiovascular events compared with essential hypertensives. To date, 3 familial forms of PA have been described and termed familial hyperaldosteronism types I, II, and III (FH-I to -III). The aim of this study was to investigate the prevalence and clinical characteristics of the 3 forms of FH in a large population of PA patients. Three-hundred consecutive PA patients diagnosed in our unit were tested by long-PCR of the CYP11B1/CYP11B2 hybrid gene that causes FH-I, and all of the available relatives of PA patients were screened to confirm or exclude PA and, thus, FH-II. Urinary 18-hydroxycortisol and 18-oxocortisol were measured in all of the familial PA patients. Two patients were diagnosed with FH-I (prevalence: 0.66%), as well as 21 of their relatives, and clinical phenotypes of the 2 affected families varied markedly. After exclusion of families who refused testing and those who were not informative, 199 families were investigated, of which 12 were diagnosed with FH-II (6%) and an additional 15 individuals had confirmed PA; clinical and biochemical phenotypes of FH-II families were not significantly different from sporadic PA patients. None of the families displayed a phenotype compatible with FH-III diagnosis. Our study demonstrates that familial forms of hyperaldosteronism are more frequent than previously expected and reinforces the recommendation of the Endocrine Society Guidelines to screen all first-degree hypertensive relatives of PA patients.